Market research
BAYERCROP.NSE Bayer CropScience Limited
NSE INR Basic Materials
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 179B
- P/E ratio
- 24.42
- Analyst target
- 5126.4287
- Dividend yield
- 0.0%
- Beta
- 0.22
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- ISIN
- INE462A01022
- Market cap
- 179B
- P/E ratio
- 24.42
- Analyst target
- 5126.4287
- Dividend yield
- 0.0%
- Beta
- 0.22
About
About Bayer CropScience Limited
Bayer CropScience Limited, together with its subsidiaries, engages in the agriculture business in India, Germany, Bangladesh, and internationally. The company manufactures, sells, and distributes agrochemical products, including insecticides, fungicides, herbicides, seed treatment solutions, and biologicals; produces, sells, and distributes hybrid corn seeds, as well as rice, fruits, and vegetables; and integrates digital farming solutions, such as remote sensing, artificial intelligence, IoT, drones, and data analytics. It also offers medicines for various therapeutic areas comprising cardiology, diabetes, kidney health, women's health, oncology, ophthalmology, and radiology; and over-the-counter products, including analgesics, nutrition, allergy, dermatology, and digestives. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the BAYERCROP.NSE discussion.
5 years, 5 months ago
Bayer CropScience Limited is currently in a long term uptrend where the price is trading 5.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 5.9.
Bayer CropScience Limited's total revenue rose by 7.5% to $9B since the same quarter in the previous year.
Its net income has dropped by 132.7% to $-451M since the same quarter in the previous year.
Finally, its free cash flow grew by 388.3% to $4B since the same quarter in the previous year.
Based on the above factors, Bayer CropScience Limited gets an overall score of 4/5.